CSBR logo

Champions Oncology (CSBR) Shareholders Equity

Annual Shareholders Equity

-$1.90 M
-$6.54 M-141.05%

30 April 2024

CSBR Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

-$332.00 K
+$1.57 M+82.55%

31 July 2024

CSBR Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CSBR Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-141.1%-457.0%
3 y3 years-125.6%-104.1%
5 y5 years-185.0%-115.7%

CSBR Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-120.9%at low-103.6%+83.9%
5 y5 years-120.9%at low-103.6%+83.9%
alltimeall time-120.9%at low-103.6%+95.4%

Champions Oncology Shareholders Equity History

DateAnnualQuarterly
July 2024
-
-$332.00 K(-82.6%)
Apr 2024
-$1.90 M(-141.0%)
-$1.90 M(-7.5%)
Jan 2024
-
-$2.06 M(-2312.9%)
Oct 2023
-
$93.00 K(-95.1%)
July 2023
-
$1.90 M(-59.0%)
Apr 2023
$4.64 M(-49.0%)
$4.64 M(-34.4%)
Jan 2023
-
$7.06 M(-23.0%)
Oct 2022
-
$9.17 M(+2.1%)
July 2022
-
$8.98 M(-1.2%)
Apr 2022
$9.10 M(+22.5%)
$9.10 M(-1.5%)
Jan 2022
-
$9.24 M(+14.4%)
Oct 2021
-
$8.07 M(+7.1%)
July 2021
-
$7.54 M(+1.5%)
Apr 2021
$7.43 M(+45.7%)
$7.43 M(-5.6%)
Jan 2021
-
$7.87 M(+14.1%)
Oct 2020
-
$6.89 M(+25.0%)
July 2020
-
$5.51 M(+8.1%)
Apr 2020
$5.10 M(+127.8%)
$5.10 M(+60.5%)
Jan 2020
-
$3.18 M(+50.3%)
Oct 2019
-
$2.11 M(+22.3%)
July 2019
-
$1.73 M(-22.8%)
Apr 2019
$2.24 M(>+9900.0%)
$2.24 M(-3.7%)
Jan 2019
-
$2.32 M(+16.6%)
Oct 2018
-
$1.99 M(+230.9%)
July 2018
-
$602.00 K(>+9900.0%)
Apr 2018
$3000.00(-99.3%)
$3000.00(-99.4%)
Jan 2018
-
$472.00 K(+26.5%)
Oct 2017
-
$373.00 K(+28.6%)
July 2017
-
$290.00 K(-27.5%)
Apr 2017
$400.00 K(+68.1%)
$400.00 K(-80.4%)
Jan 2017
-
$2.04 M(-36.3%)
Oct 2016
-
$3.21 M(+0.9%)
July 2016
-
$3.18 M(+1234.5%)
Apr 2016
$238.00 K(-97.0%)
$238.00 K(-89.5%)
Jan 2016
-
$2.26 M(-44.9%)
Oct 2015
-
$4.10 M(-30.5%)
July 2015
-
$5.90 M(-26.8%)
Apr 2015
$8.06 M(+152.1%)
$8.06 M(-294.5%)
Jan 2015
-
-$4.14 M(+123.0%)
Oct 2014
-
-$1.86 M(-523.2%)
July 2014
-
$439.00 K(-86.3%)
Apr 2014
$3.20 M(-58.4%)
$3.20 M(-28.7%)
Jan 2014
-
$4.49 M(+8.4%)
Oct 2013
-
$4.14 M(-30.9%)
July 2013
-
$5.99 M(-22.0%)
Apr 2013
$7.68 M(+166.4%)
$7.68 M(-17.8%)
Jan 2013
-
$9.34 M(-229.9%)
Oct 2012
-
-$7.18 M(+23.1%)
July 2012
-
-$5.84 M(-302.6%)
DateAnnualQuarterly
Apr 2012
$2.88 M(>+9900.0%)
$2.88 M(-185.2%)
Jan 2012
-
-$3.38 M(+41.6%)
Oct 2011
-
-$2.39 M(+140.6%)
July 2011
-
-$992.00 K(-5321.1%)
Apr 2011
$19.00 K(-98.8%)
$19.00 K(-99.1%)
Jan 2011
-
$2.19 M(+58.3%)
Oct 2010
-
$1.39 M(+8.9%)
July 2010
-
$1.27 M(-19.2%)
Apr 2010
$1.58 M(-17.7%)
$1.58 M(-8.6%)
Jan 2010
-
$1.73 M(+509.9%)
Oct 2009
-
$283.00 K(-49.5%)
July 2009
-
$560.00 K(-70.8%)
Apr 2009
$1.92 M(-47.3%)
$1.92 M(-35.1%)
Jan 2009
-
$2.95 M(-14.5%)
Oct 2008
-
$3.45 M(-3.4%)
July 2008
-
$3.58 M(-1.7%)
Apr 2008
$3.64 M(-1493.0%)
$3.64 M(+140.8%)
Jan 2008
-
$1.51 M(+83.0%)
Oct 2007
-
$825.20 K(-11.7%)
July 2007
-
$934.30 K(-457.8%)
Apr 2007
-$261.10 K(-61.1%)
-$261.10 K(-26.7%)
Jan 2007
-
-$356.10 K(-0.2%)
Oct 2006
-
-$356.90 K(-48.1%)
July 2006
-
-$687.80 K(+2.6%)
Apr 2006
-$670.50 K(+82.8%)
-$670.50 K(-0.5%)
Jan 2006
-
-$673.80 K(+4.4%)
Oct 2005
-
-$645.70 K(+7.2%)
July 2005
-
-$602.60 K(+64.3%)
Apr 2005
-$366.80 K(+83.1%)
-$366.80 K(-18.7%)
Jan 2005
-
-$451.10 K(+143.6%)
Oct 2004
-
-$185.20 K(+52.2%)
July 2004
-
-$121.70 K(-39.2%)
Apr 2004
-$200.30 K(-4.5%)
-$200.30 K(+42.7%)
Jan 2004
-
-$140.40 K(+34.6%)
Oct 2003
-
-$104.30 K(-59.4%)
July 2003
-
-$257.10 K(+22.6%)
Apr 2003
-$209.70 K(+4094.0%)
-$209.70 K(+44.6%)
Jan 2003
-
-$145.00 K(+275.6%)
Oct 2002
-
-$38.60 K(-48.9%)
July 2002
-
-$75.50 K(+1410.0%)
Apr 2002
-$5000.00(-103.3%)
-$5000.00(-112.7%)
Jan 2002
-
$39.30 K(-67.3%)
Oct 2001
-
$120.10 K(+2.5%)
July 2001
-
$117.20 K(-22.4%)
Apr 2001
$151.10 K(-83.1%)
$151.10 K(-60.4%)
Jan 2001
-
$381.80 K(-47.2%)
Oct 2000
-
$723.20 K(-18.1%)
July 2000
-
$882.90 K(-1.0%)
Apr 2000
$891.70 K
$891.70 K(-0.9%)
Jan 2000
-
$900.00 K

FAQ

  • What is Champions Oncology annual stockholders equity?
  • What is the all time high annual shareholders equity for Champions Oncology?
  • What is Champions Oncology annual shareholders equity year-on-year change?
  • What is Champions Oncology quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Champions Oncology?
  • What is Champions Oncology quarterly shareholders equity year-on-year change?

What is Champions Oncology annual stockholders equity?

The current annual shareholders equity of CSBR is -$1.90 M

What is the all time high annual shareholders equity for Champions Oncology?

Champions Oncology all-time high annual stockholders equity is $9.10 M

What is Champions Oncology annual shareholders equity year-on-year change?

Over the past year, CSBR annual stockholders equity has changed by -$6.54 M (-141.05%)

What is Champions Oncology quarterly stockholders equity?

The current quarterly shareholders equity of CSBR is -$332.00 K

What is the all time high quarterly shareholders equity for Champions Oncology?

Champions Oncology all-time high quarterly stockholders equity is $9.34 M

What is Champions Oncology quarterly shareholders equity year-on-year change?

Over the past year, CSBR quarterly stockholders equity has changed by -$425.00 K (-456.99%)